398 related articles for article (PubMed ID: 34880424)
1. Computational analysis of cancer genome sequencing data.
Cortés-Ciriano I; Gulhan DC; Lee JJ; Melloni GEM; Park PJ
Nat Rev Genet; 2022 May; 23(5):298-314. PubMed ID: 34880424
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatic Methods to Identify Mutational Signatures in Cancer.
Islam SMA; Alexandrov LB
Methods Mol Biol; 2021; 2185():447-473. PubMed ID: 33165866
[TBL] [Abstract][Full Text] [Related]
3. Computational methods for DNA copy-number analysis of tumors.
Kendall J; Krasnitz A
Methods Mol Biol; 2014; 1176():243-59. PubMed ID: 25030933
[TBL] [Abstract][Full Text] [Related]
4. A survey of tools for variant analysis of next-generation genome sequencing data.
Pabinger S; Dander A; Fischer M; Snajder R; Sperk M; Efremova M; Krabichler B; Speicher MR; Zschocke J; Trajanoski Z
Brief Bioinform; 2014 Mar; 15(2):256-78. PubMed ID: 23341494
[TBL] [Abstract][Full Text] [Related]
5. Computational analysis in cancer exome sequencing.
Evans P; Kong Y; Krauthammer M
Methods Mol Biol; 2014; 1176():219-27. PubMed ID: 25030931
[TBL] [Abstract][Full Text] [Related]
6. Computational methods for detecting copy number variations in cancer genome using next generation sequencing: principles and challenges.
Liu B; Morrison CD; Johnson CS; Trump DL; Qin M; Conroy JC; Wang J; Liu S
Oncotarget; 2013 Nov; 4(11):1868-81. PubMed ID: 24240121
[TBL] [Abstract][Full Text] [Related]
7. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of methods for identifying somatic copy number alterations from deep sequencing data.
Alkodsi A; Louhimo R; Hautaniemi S
Brief Bioinform; 2015 Mar; 16(2):242-54. PubMed ID: 24599115
[TBL] [Abstract][Full Text] [Related]
9. Understanding genomic alterations in cancer genomes using an integrative network approach.
Wang E
Cancer Lett; 2013 Nov; 340(2):261-9. PubMed ID: 23266571
[TBL] [Abstract][Full Text] [Related]
10. Identification of Copy Number Alterations from Next-Generation Sequencing Data.
Nabavi S; Zare F
Adv Exp Med Biol; 2022; 1361():55-74. PubMed ID: 35230683
[TBL] [Abstract][Full Text] [Related]
11. Emerging patterns of somatic mutations in cancer.
Watson IR; Takahashi K; Futreal PA; Chin L
Nat Rev Genet; 2013 Oct; 14(10):703-18. PubMed ID: 24022702
[TBL] [Abstract][Full Text] [Related]
12. Deconvolving tumor purity and ploidy by integrating copy number alterations and loss of heterozygosity.
Li Y; Xie X
Bioinformatics; 2014 Aug; 30(15):2121-9. PubMed ID: 24695406
[TBL] [Abstract][Full Text] [Related]
13. Identification of mutations in zebrafish using next-generation sequencing.
Henke K; Bowen ME; Harris MP
Curr Protoc Mol Biol; 2013 Oct; 104():7.13.1-7.13.33. PubMed ID: 24510885
[TBL] [Abstract][Full Text] [Related]
14. Computational methods and resources for the interpretation of genomic variants in cancer.
Tian R; Basu MK; Capriotti E
BMC Genomics; 2015; 16 Suppl 8(Suppl 8):S7. PubMed ID: 26111056
[TBL] [Abstract][Full Text] [Related]
15. Mutational signatures: the patterns of somatic mutations hidden in cancer genomes.
Alexandrov LB; Stratton MR
Curr Opin Genet Dev; 2014 Feb; 24(100):52-60. PubMed ID: 24657537
[TBL] [Abstract][Full Text] [Related]
16. Genomic sequencing in cancer.
Tuna M; Amos CI
Cancer Lett; 2013 Nov; 340(2):161-70. PubMed ID: 23178448
[TBL] [Abstract][Full Text] [Related]
17. Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes.
Cheng F; Zhao J; Zhao Z
Brief Bioinform; 2016 Jul; 17(4):642-56. PubMed ID: 26307061
[TBL] [Abstract][Full Text] [Related]
18. TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy.
Gray PN; Vuong H; Tsai P; Lu HM; Mu W; Hsuan V; Hoo J; Shah S; Uyeda L; Fox S; Patel H; Janicek M; Brown S; Dobrea L; Wagman L; Plimack E; Mehra R; Golemis EA; Bilusic M; Zibelman M; Elliott A
Oncotarget; 2016 Oct; 7(42):68206-68228. PubMed ID: 27626691
[TBL] [Abstract][Full Text] [Related]
19. CLImAT-HET: detecting subclonal copy number alterations and loss of heterozygosity in heterogeneous tumor samples from whole-genome sequencing data.
Yu Z; Li A; Wang M
BMC Med Genomics; 2017 Mar; 10(1):15. PubMed ID: 28298214
[TBL] [Abstract][Full Text] [Related]
20. MixClone: a mixture model for inferring tumor subclonal populations.
Li Y; Xie X
BMC Genomics; 2015; 16 Suppl 2(Suppl 2):S1. PubMed ID: 25707430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
